Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jodi Skiles"'
Autor:
Festus Njuguna, Hugo A. Martijn, Robert Tenge Kuremu, Peter Saula, Patel Kirtika, Gilbert Olbara, Sandra Langat, Steve Martin, Jodi Skiles, Terry Vik, Gertjan J.L. Kaspers, Saskia Mostert
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 5, Pp 555-562 (2017)
Purpose: Wilms tumor is the commonest renal malignancy in childhood. Survival in high-income countries is approximately 90%, whereas in low-income countries, it is less than 50%. This study assessed treatment outcomes of patients with Wilms tumor at
Externí odkaz:
https://doaj.org/article/85c7386bb6bc4cdfa21780723da02ac3
Publikováno v:
Pediatric Critical Care Medicine. 24:e170-e178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a201f299d0649718ae4ecd69a6c1df8
https://doi.org/10.1097/pcc.0000000000003153
https://doi.org/10.1097/pcc.0000000000003153
Autor:
Tyler S. Severance, Festus Njuguna, Gilbert Olbara, Maureen Kugo, Sandra Langat, Saskia Mostert, Larissa Klootwijk, Jodi Skiles, Scott L. Coven, Kathleen M. Overholt, Gertjan Kaspers, Terry A. Vik
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(10)
Western Kenya is home to approximately 24 million people, with 10 million children under the age of 15 years.Here, we describe a multidisciplinary and sequential approach to better evaluate the complex factors affecting the lack of appropriate diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54ea1e2cb695899cd6ef0b7270fc16d
https://pubmed.ncbi.nlm.nih.gov/35593641
https://pubmed.ncbi.nlm.nih.gov/35593641
Publikováno v:
Open Forum Infectious Diseases
Background CAR-T Cell Therapy is approved for the treatment of pediatric patients with relapsed/refractory B-ALL. Lentiviral vector technology, highly modified from HIV-1, is used to induce stable, long-term transgene expression by integration into t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01381740e4e8794d5e4030f452b2699e
http://europepmc.org/articles/PMC8643856
http://europepmc.org/articles/PMC8643856
Autor:
Rebecca A, Marsh, Carl E, Allen, Kenneth L, McClain, Joanna L, Weinstein, Julie, Kanter, Jodi, Skiles, Nadine D, Lee, Shakila P, Khan, Julia, Lawrence, Jun Q, Mo, Jack J, Bleesing, Alexandra H, Filipovich, Michael B, Jordan
Publikováno v:
Pediatric bloodcancer. 60(1)
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that remains difficult to treat. Even with current standard HLH therapy, only approximately half of patients will experience complete resolution of disease, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76a0659eceaf50c6d87df2839279196f
https://pubmed.ncbi.nlm.nih.gov/22522603
https://pubmed.ncbi.nlm.nih.gov/22522603